ISTANBUL MS DAYS

SCIENTIFIC PROGRAM

ISTANBUL MS DAYS IV 2019

“The myth of discordance in biology, imaging and clinical phenotypes in MS!”

 

 

31 October 2019, Thursday 

13:00 – 14:00 Oral presentations
14:00 – 15:30  Turkish Panel: Diagnosing and managing MS and related disorders in Turkey in 2019
  Chair: Omer Faruk Turan
15:30 – 16:00  Official opening
  Aksel Siva, Husnu Efendi, Melih Tutuncu
   
16:00 – 17:00  Session-1: Opening session
  Chairs: Egemen Idiman & Serhan Sevim
16:00 – 16:30 Imaging as a primary outcome as opposed to clinical outcomes in MS
  Orhun Kantarci
16:30 – 17:00 Novel imaging technologies to study the interactions between the brain, immune system, and the vasculature
  Katerina Akassoglou
17:00 - 17:15  Panel Discussion
17:15 - 17:30 Introduction to the special panel
  Emmanuelle Waubant
17:30 – 18:45 Istanbul MS Days - 2019 Special Panel: MS in diverse populations; age extremes, ethnic diversity and sex diversity
  Chairs: Husnu Efendi & Emmanuelle Waubant
  Panelists: Naila Makhani, Alexey Boyko, Mohammad Ali Sahraian, Riadh Gouider, Najib Kissani
   
18:45 – 19:00 Break
   
19:00 – 19:45  Inspirational speaker 
   

1 November 2019, Friday 

   
08:00 – 09:00 Debate sessions X 3 in parallel
09:00 - 12:30  Session-2 "Imaging markers in MS and beyond!"
  Chairs: Rana Karabudak & Vilas Menon
09:00 – 09:20  Imaging markers of clinical outcomes in MS
  Daniel Pelletier
09:20 – 09:40  Evolving imaging diagnostic criteria for MS 
  Matilde Inglese
09:40 – 10:00 The current impact of imaging on treatment choices and switches
  Darin Okuda
10:00 – 10:30 Coffee break
10:30 – 10:50 Imaging plasticity in MS 
  Nicola De Stefano
10:50 – 11:10 Beyond imaging - clinically useful phenotypic markers of MS
  Claire Riley
11:10 – 11:30 Homeostatic Immune-Glial Cell Circuits in Human Brain
  David Hafler
11:50 – 12:30 Panel discussion
   
12:30 – 13:40  Lunch break
   
13:40 – 17:00  Session-3 "Imaging Pathology & Immunology in MS" 
  Chairs: Gulsen Akman & Anat Achiron  
13:40 – 14:00 Which pathology should be imaged in MS? 
  Bruce Trapp
14:00 – 14:20 Available imaging correlates of pathology in MS 
  Wolfgang Bruck
14:20 – 14:40 Opportunities to bridge the gap between neuropathology and in-vivo imaging through PET 
  Bruno Stankoff
14:40 – 15:10 Coffee break
15:10 – 15:30 Specific imaging markers for specific aspects of the immune system
  Amit Bar-Or
15:30 – 15:50 Imaging the glymphatic system and its potential implications in MS
  Daniel Reich
15:50 – 16:10 The CSF correlates of clinical and imaging phenotypes in MS 
  Thomas Berger
16:10 – 17:00 Discussion
   
17:00 – 17:15 Break
   
  Chair: Muhtesem Gedizlioglu & Serkan Ozakbas
17:15 – 17:45  Atypical MS with a focus on genetics 
  Jack Antel 
18:00 – 19:00 Poster session
20:00 – 22:30  Dinner
   

2 November 2019, Saturday

   
08:00 – 09:00 Poster session
09:00 – 12:30 Session-4 "Common Imaging for common phenotypes among different neurological disorders" 
  Chairs: Orhun Kantarcı & Samia J. Khoury 
09:00 – 09:20  Repair in neurological disorders 
  Catherine Lubetzki 
09:20 – 09:40  Multimodality imaging in neurodegeneration
  Kejal Kantarci
09:40 – 10:00 Atrophy as a surrogate for the phases of MS
  Christina Azevedo
10:00 – 10:30 Coffee break
10:30 – 10:50 Management of asymptomatic MS or RIS, what to do and do we need updated criteria?
  Christina Lebrun-Frenay
10:50 – 11:10 Imaging outcomes in clinical trials – learnings, current and future challenges 
  Ludwig Kappos 
11:10 – 12:00 Panel discussion 
   
  Chair: Murat Terzi & TBA
12:00 – 12:30 MS treatment update in 2019 
  Aksel Siva
12:40 – 13:40  Lunch break
   
13:40 – 17:45 Session-5 "MS vs Non-MS CNS inflammatory disorders – clinical & imaging phenotypes" 
  Chairs: Ayse Altıntas & Nikolaos Grigoriadis
13:40 – 14:00 MS mimickers 
  Brian G Weinshenker 
14:00 – 14:20 Interpreting antibody assay results in NMOSD and beyond,  sensitivities, specificities and cohort selection"
  Jacqueline Palace
14:20 – 14:40 NMO & MOG-SD 
  Kazuo Fujihara
14:40 – 15:00 Optimization of relapse treatment in MS and NMO 
  Andrew Chan
15:00 – 15:20 The potential of OCT for diagnostic criteria in MS and Non-MS CNS inflammatory disorders
  Axel Petzgold
15:20 – 15:40 Break
15:40 – 16:00 How effective is MRI in differentiating multiple sclerosis from its imaging mimics?
  Mike P. Wattjes
16:00 – 16:20 Neuro-Behcet Syndrome
  Ugur Uygunoglu
16:20 – 16:40 Systemic autoimmune disorders and CNS
  Cavit Boz
16:40 – 17:00 Case studies in non-MS inflammatory of CNS disorders
  Aslı Tuncer
17:00 – 17:20 Treatment of non-MS inflammatory CNS disorders
  Murat Kürtüncü
17:20 – 18:00 Panel discussion
18:00 – 18:15 Coffee Break
18:15 – 19:15 Meeting Summary
19:15 Closure
20:00 – 22:30  Dinner